Rheumatic And Autoimmune Diseases
'Quelling anxiety' essential for rheumatologists ensuring safe pregnancies
DESTIN, Fla. — Ongoing, frank discussions about reproductive health with patients of childbearing age is critical to safe pregnancy outcomes, according to a presenter at the Congress of Clinical Rheumatology East.
CAR T-cell therapy remains the 'hottest story' in lupus, autoimmune disease
DESTIN, Fla. — Positive results for chimeric antigen receptor T-cell therapy in systemic sclerosis and myositis have added fuel to the fire of recent landmark data in lupus, said a speaker at the Congress of Clinical Rheumatology East.
A rare day for rare diseases: Latest data and findings for Rare Disease Day
It’s not too often one sees Feb. 29 on the calendar, which makes it a perfect time for Rare Disease Day, dedicated to recognizing conditions that, in the words of the European Commission on Public Health, require “special combined efforts.”
‘Ubiquitous’ COVID-19 may help rheumatologists understand integrated immune response
SCOTTSDALE, Ariz. —The COVID-19 pandemic could enable better understanding of the relationship between infection and autoimmunity, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.
Patients with autoimmune disease have 30% higher risk for perinatal depression
Patients with autoimmune disease demonstrate a 30% higher risk for perinatal depression, while those with perinatal depression have a 30% higher risk for subsequent autoimmune disease, according to data published in Molecular Psychiatry.
It's in the Air: Silica exposure and the risk of autoimmunity, Part 4
What is silica? How does it impact your risk of developing autoimmunity if you inhale it, inject it or even snort it up your nose? Listen and find out!
Psilocybin has potential to treat depression, anxiety despite legal ‘question mark’
SAN DIEGO — Psilocybin has emerged as a potential treatment for depression and anxiety, including among patients with chronic rheumatic or autoimmune conditions, according to a speaker at the 2023 Congress of Clinical Rheumatology West.
Johns Hopkins named top hospital for rheumatology for sixth year by U.S. News
Johns Hopkins has been named the best hospital for rheumatology in the United States for the sixth consecutive year by U.S. News & World Report, which recently released its Best Hospitals Survey for the 2023-2024 year.
Hooked on Rheum with Gwenesta B. Melton, MD
During my internal medicine training, I was fascinated by immunology and marveled at the antigen and antibody formations formulated with exposures to medications, environmental agents or genetic predispositions.
VEXAS syndrome ‘more common than expected’
VEXAS syndrome is “more common than expected” in both men and women, with one in 13,591 individuals demonstrating a UBA1 disease-causing variant, according to data published in JAMA.